Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 8,494,151 | 8,494,151 | 0 | $426.66M | $373.49M | 21.72% | -$53.17M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 2,025,000 | 2,025,000 | 0 | $79.46M | $91.63M | 5.33% | +$12.17M |
| Arcellx Inc COMMON STOCK | 1,780,000 | 1,525,000 | -255,000 | $123.80M | $84.16M | 4.90% | -$39.63M |
| Vaxcyte, Inc.(PCVX) | 685,000 | 1,100,000 | +415,000 | $46.79M | $83.06M | 4.83% | +$36.27M |
| Longboard Pharmaceuticals In | 3,353,141 | 2,790,462 | -562,679 | $72.43M | $75.43M | 4.39% | +$3.00M |
| EyePoint, Inc.(EYPT) | 6,893,235 | 8,325,000 | +1,431,765 | $142.48M | $72.43M | 4.21% | -$70.06M |
| Rapport Therapeutics, Inc.(RAPP) | 0 | 2,940,283 | +2,940,283 | $0 | $68.39M | 3.98% | +$68.39M |
| Crinetics Pharmaceuticals In | 1,150,000 | 1,350,000 | +200,000 | $53.83M | $60.47M | 3.52% | +$6.63M |
| Edgewise Therapeutics, Inc.(EWTX) | 3,006,534 | 3,006,534 | 0 | $54.84M | $54.15M | 3.15% | -$691.5K |
| Merus N V | 715,000 | 840,000 | +125,000 | $32.20M | $49.70M | 2.89% | +$17.51M |
| BridgeBio Pharma, Inc.(BBIO) | 3,203,029 | 1,858,351 | -1,344,678 | $99.04M | $47.07M | 2.74% | -$51.97M |
| Insmed Incorporated(INSM) | 575,000 | 675,000 | +100,000 | $15.60M | $45.23M | 2.63% | +$29.63M |
| Newamsterdam Pharma Company ORDINARY SHARES | 1,500,000 | 2,300,000 | +800,000 | $35.48M | $44.18M | 2.57% | +$8.71M |
| Janux Therapeutics, Inc.(JANX) | 750,000 | 1,050,000 | +300,000 | $28.24M | $43.98M | 2.56% | +$15.75M |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 400,000 | +400,000 | $0 | $32.20M | 1.87% | +$32.20M |
| CG Oncology, Inc.(CGON) | 800,000 | 975,000 | +175,000 | $35.12M | $30.78M | 1.79% | -$4.34M |
| Helix Acquisition Corp IiCL A | 2,909,000 | 2,909,000 | 0 | $30.25M | $29.73M | 1.73% | -$523.6K |
| Alumis Inc | 0 | 2,147,400 | +2,147,400 | $0 | $28.56M | 1.66% | +$28.56M |
| Praxis Precision Medicines, Inc.(PRAX) | 1,310,000 | 685,000 | -625,000 | $79.94M | $28.33M | 1.65% | -$51.60M |
| ABIVAX Société AnonymeADS(ABVX) | 2,130,000 | 2,130,000 | 0 | $30.46M | $28.16M | 1.64% | -$2.30M |
| Biohaven Ltd.(BHVN) | 616,963 | 801,963 | +185,000 | $33.74M | $27.84M | 1.62% | -$5.91M |
| UroGen Pharma Ltd.(URGN) | 0 | 1,650,000 | +1,650,000 | $0 | $27.69M | 1.61% | +$27.69M |
| Pharvaris N V COM | 1,711,460 | 1,466,460 | -245,000 | $39.55M | $27.57M | 1.60% | -$11.98M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 2,125,000 | 2,525,000 | +400,000 | $21.06M | $23.48M | 1.37% | +$2.42M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 125,000 | +125,000 | $0 | $19.75M | 1.15% | +$19.75M |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 1,125,000 | +1,125,000 | $0 | $19.62M | 1.14% | +$19.62M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 550,000 | 475,000 | -75,000 | $23.83M | $19.50M | 1.13% | -$4.33M |
| Cargo Therapeutics Inc | 1,182,563 | 1,182,563 | 0 | $26.39M | $19.42M | 1.13% | -$6.98M |
| Y-Mabs Therapeutics Inc | 0 | 1,450,000 | +1,450,000 | $0 | $17.52M | 1.02% | +$17.52M |
| Avidity Biosciences Inc | 0 | 425,000 | +425,000 | $0 | $17.36M | 1.01% | +$17.36M |
| Biomea Fusion, Inc.(BMEA) | 3,570,872 | 3,570,872 | 0 | $53.38M | $16.07M | 0.93% | -$37.32M |
| Centessa Pharmaceuticals PlcADS | 561,600 | 1,611,600 | +1,050,000 | $6.35M | $14.55M | 0.85% | +$8.21M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,139,102 | 500,000 | -1,639,102 | $77.76M | $13.59M | 0.79% | -$64.17M |
| Silence Therapeutics plcADS(SLN) | 625,000 | 625,000 | 0 | $13.50M | $11.88M | 0.69% | -$1.63M |
| ArriVent BioPharma, Inc.(AVBP) | 515,000 | 515,000 | 0 | $9.20M | $9.55M | 0.56% | +$355.4K |
| Engene Holdings Inc COM | 1,000,000 | 1,000,000 | 0 | $16.95M | $9.43M | 0.55% | -$7.52M |
| Korro Bio, Inc.(KRRO) | 529,170 | 265,826 | -263,344 | $47.63M | $9.00M | 0.52% | -$38.62M |
| IDEAYA Biosciences, Inc.(IDYA) | 450,000 | 245,000 | -205,000 | $19.75M | $8.60M | 0.50% | -$11.14M |
| GH Research PLC(GHRS) | 593,043 | 593,043 | 0 | $6.32M | $6.91M | 0.40% | +$593.0K |
| Lantheus Holdings, Inc.(LNTH) | 75,000 | 75,000 | 0 | $4.67M | $6.02M | 0.35% | +$1.35M |
| Stoke Therapeutics, Inc.(STOK) | 427,163 | 427,163 | 0 | $5.77M | $5.77M | 0.34% | +$4.3K |
| Mersana Therapeutics Inc | 2,600,000 | 2,600,000 | 0 | $11.65M | $5.23M | 0.30% | -$6.42M |
| Neurogene Inc.(NGNE) | 538,714 | 107,344 | -431,370 | $27.42M | $3.91M | 0.23% | -$23.51M |
| Yarrow Bioscience Inc(YARW) | 1,394,336 | 1,394,336 | 0 | $4.28M | $2.75M | 0.16% | -$1.53M |
| Compass Therapeutics, Inc.(CMPX) | 5,560,300 | 2,030,823 | -3,529,477 | $11.01M | $2.03M | 0.12% | -$8.98M |
| Verve Therapeutics Inc | 350,000 | 350,000 | 0 | $4.65M | $1.71M | 0.10% | -$2.94M |
| Rapt Therapeutics Inc | 496,750 | 496,750 | 0 | $4.46M | $1.52M | 0.09% | -$2.95M |
| Aerovate Therapeutics Inc | 1,069,796 | 0 | -1,069,796 | $31.63M | $0 | — | -$31.63M |
| Alpine Immune Sciences Inc | 2,700,000 | 0 | -2,700,000 | $107.03M | $0 | — | -$107.03M |
| ALX Oncology Holdings Inc.(ALXO) | 3,142,079 | 0 | -3,142,079 | $35.03M | $0 | — | -$35.03M |
| Apellis Pharmaceuticals Inc COM | 400,000 | 0 | -400,000 | $23.51M | $0 | — | -$23.51M |
| Astria Therapeutics Inc | 1,300,000 | 0 | -1,300,000 | $18.30M | $0 | — | -$18.30M |
| Autolus Therapeutics plcADS(AUTL) | 6,616,667 | 0 | -6,616,667 | $42.21M | $0 | — | -$42.21M |
| BioAtla, Inc.(BCAB) | 1,170,870 | 0 | -1,170,870 | $4.03M | $0 | — | -$4.03M |
| Cabaletta Bio, Inc.(CABA) | 1,100,000 | 0 | -1,100,000 | $18.77M | $0 | — | -$18.77M |
| Disc Medicine, Inc.(IRON) | 125,000 | 0 | -125,000 | $7.78M | $0 | — | -$7.78M |
| Immuneering CorpCL A | 3,295,273 | 0 | -3,295,273 | $9.52M | $0 | — | -$9.52M |
| Kyverna Therapeutics, Inc.(KYTX) | 440,000 | 0 | -440,000 | $10.93M | $0 | — | -$10.93M |
| Marinus Pharmaceuticals Inc | 3,250,000 | 0 | -3,250,000 | $29.38M | $0 | — | -$29.38M |
| Nkarta, Inc.(NKTX) | 1,350,000 | 0 | -1,350,000 | $14.59M | $0 | — | -$14.59M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 300,000 | 0 | -300,000 | $8.08M | $0 | — | -$8.08M |
| Spyre Therapeutics, Inc.(SYRE) | 250,000 | 0 | -250,000 | $9.48M | $0 | — | -$9.48M |
| Tourmaline Bio Inc | 1,250,000 | 0 | -1,250,000 | $28.63M | $0 | — | -$28.63M |
| Ventyx Biosciences Inc | 2,710,000 | 0 | -2,710,000 | $14.90M | $0 | — | -$14.90M |